BIOG B — Biogaia AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK11.63bn
- SEK10.10bn
- SEK1.30bn
- 98
- 25
- 89
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 243 | 228 | 254 | 361 | 443 |
Depreciation | |||||
Non-Cash Items | 3.08 | -3.71 | 0.047 | -9.1 | -1.48 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -113 | -23.7 | -59.1 | -57.3 | -40.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 148 | 221 | 222 | 319 | 426 |
Capital Expenditures | -39 | -16.1 | -6.38 | -17.9 | -48.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | -121 | -0.225 | -2.37 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -39 | -16.1 | -127 | -18.1 | -50.9 |
Financing Cash Flow Items | -3.2 | -2.8 | -2.8 | -2.9 | -4.4 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -181 | 1,051 | -81.8 | -314 | -308 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -71.1 | 1,254 | 16.8 | 3.69 | 55.8 |